scholarly article | Q13442814 |
P50 | author | Ewa Sawosz | Q99559754 |
Marta Grodzik | Q42358474 | ||
P2093 | author name string | Piotr Orlowski | |
André Chwalibog | |||
Mateusz Wierzbicki | |||
Tomasz Niemiec | |||
Maciej Szmidt | |||
Katarzyna Mitura | |||
Anna Hotowy | |||
P2860 | cites work | RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma | Q24337730 |
Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
Angiogenesis in life, disease and medicine | Q29614539 | ||
Tumour vascularization: sprouting angiogenesis and beyond | Q33556162 | ||
Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway | Q33575231 | ||
Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1. | Q33715953 | ||
Angiogenesis in malignant primary and metastatic brain tumors | Q34065930 | ||
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. | Q34151513 | ||
Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors | Q34178886 | ||
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. | Q34363706 | ||
Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis. | Q51976403 | ||
NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. | Q54390268 | ||
Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells | Q54634198 | ||
Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancer | Q73589315 | ||
Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model | Q74314846 | ||
Reduced tumour progression and angiogenesis in 1,2-dimethylhydrazine mice treated with NS-398 is associated with down-regulation of cyclooxygenase-2 and decreased beta-catenin nuclear localisation | Q84376244 | ||
Pristine C(60) fullerenes inhibit the rate of tumor growth and metastasis | Q85009569 | ||
Vascular endothelial growth factor and vascular targeting of solid tumors | Q34573866 | ||
Bevacizumab for the treatment of recurrent glioblastoma | Q34982777 | ||
Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling | Q35018349 | ||
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma | Q35800509 | ||
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis | Q36371903 | ||
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF | Q36623011 | ||
Drug delivery with carbon nanotubes for in vivo cancer treatment | Q36925878 | ||
Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells | Q37418304 | ||
Glioblastoma: Part I. Current state of affairs | Q37898648 | ||
Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro | Q39617437 | ||
Shape effect of carbon nanovectors on angiogenesis | Q39756922 | ||
Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study. | Q39806013 | ||
Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma | Q39863137 | ||
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects | Q40541175 | ||
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors | Q40550209 | ||
Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis | Q41407593 | ||
Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge | Q41828347 | ||
Gold nanoparticles downregulate VEGF-and IL-1β-induced cell proliferation through Src kinase in retinal pigment epithelial cells | Q42910251 | ||
Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties | Q43262967 | ||
Antiangiogenic properties of silver nanoparticles | Q43287968 | ||
Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent | Q44799510 | ||
Significance of blood vessel leakiness in cancer. | Q45931116 | ||
Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. | Q45989801 | ||
Bevacizumab and recurrent malignant gliomas: a European perspective | Q48305390 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanoparticle | Q61231 |
glioblastoma | Q282142 | ||
P304 | page(s) | 3041-3048 | |
P577 | publication date | 2011-11-25 | |
P1433 | published in | International Journal of Nanomedicine | Q6051502 |
P1476 | title | Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo. | |
P478 | volume | 6 |
Q41837514 | Analysis of the cytotoxicity of hierarchical nanoporous graphenic carbon against human glioblastoma grade IV cells |
Q55362306 | Antiangiogenic and antiapoptotic effects of green-synthesized zinc oxide nanoparticles using Sargassum muticum algae extraction. |
Q92354274 | Antiangiogenic properties of nanoparticles: a systematic review |
Q26825938 | Application of the chick embryo chorioallantoic membrane in neurosurgery disease |
Q36386383 | Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment. |
Q37167736 | Carbon nanoparticles downregulate expression of basic fibroblast growth factor in the heart during embryogenesis |
Q40389354 | Comparison of anti-angiogenic properties of pristine carbon nanoparticles |
Q47119535 | Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics. |
Q64273672 | Degradation of Mitochondria and Oxidative Stress as the Main Mechanism of Toxicity of Pristine Graphene on U87 Glioblastoma Cells and Tumors and HS-5 Cells |
Q64254519 | Diamond Nanoparticles Downregulate Expression of and in Glioma Cells |
Q28554730 | Diamond Nanoparticles Modify Curcumin Activity: In Vitro Studies on Cancer and Normal Cells and In Ovo Studies on Chicken Embryo Model |
Q42373821 | Diamond, graphite, and graphene oxide nanoparticles decrease migration and invasiveness in glioblastoma cell lines by impairing extracellular adhesion |
Q60909669 | Effects of Reduced Graphene Oxides on Apoptosis and Cell Cycle of Glioblastoma Multiforme |
Q60921316 | Graphene oxide down-regulates genes of the oxidative phosphorylation complexes in a glioblastoma |
Q35137283 | In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma |
Q39200051 | In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells |
Q47125744 | Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme |
Q28551503 | Long Term Influence of Carbon Nanoparticles on Health and Liver Status in Rats |
Q42835918 | Nano-nutrition of chicken embryos. The effect of in ovo administration of diamond nanoparticles and L-glutamine on molecular responses in chicken embryo pectoral muscles. |
Q37134602 | Nanodiamonds for Medical Applications: Interaction with Blood in Vitro and in Vivo |
Q60302477 | Nanostructures of diamond, graphene oxide and graphite inhibit CYP1A2, CYP2D6 and CYP3A4 enzymes and downregulate their genes in liver cells |
Q54115723 | Quinazoline clubbed 1,3,5-triazine derivatives as VEGFR2 kinase inhibitors: design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity. |
Q92637425 | Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer |
Q42358426 | Silver nanoparticles administered to chicken affect VEGFA and FGF2 gene expression in breast muscle and heart |
Search more.